| scholarly article | Q13442814 |
| P2093 | author name string | Lee T | |
| Karon M | |||
| Momparler RL | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2482-2488 | |
| P577 | publication date | 1974-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Kinetic studies on phosphorylation of 5-azacytidine with the purified uridine-cytidine kinase from calf thymus | |
| P478 | volume | 34 |
| Q37649663 | AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine |
| Q41730013 | DNA methylation as a target for drug design |
| Q28541605 | DNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in SW48 and HT-29 colorectal cancer cells |
| Q37627821 | Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. |
| Q42243845 | Quantitative determination of nucleosides and their phosphate esters—1. The acidic nucleosides, 3-deazauridine and 6-azauridine |
| Q36015018 | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| Q33876297 | Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes |
| Q37765469 | Therapy with azanucleosides for myelodysplastic syndromes |
| Q90591550 | Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer |
Search more.